Growth Metrics

Nexgel (NXGL) Accumulated Expenses (2018 - 2025)

Nexgel posted quarterly Accumulated Expenses of $460000.0 for Q4 2025, up 48.39% year-on-year from $310000.0 in Q4 2024, and down 13.21% on a QoQ basis from $530000.0 in Q3 2025.

Nexgel (NXGL) has 8 years of Accumulated Expenses data on file, last reported at $460000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses rose 48.39% year-over-year to $460000.0; the trailing twelve-month figure through Dec 2025 stood at $460000.0 (up 48.39% YoY), and the FY2025 full-year result was $460000.0, up 48.39% from the prior year.
  • Accumulated Expenses for Q4 2025 stood at $460000.0, down from $530000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $609000.0 in Q3 2024 and bottomed at $48000.0 in Q3 2022.
  • The 5-year median for Accumulated Expenses is $121000.0 (2022), against an average of $220600.0.
  • The widest annual swing landed in 2024, when Accumulated Expenses tumbled 51.49%; it then surged 507.27% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $62000.0 in 2021, then jumped by 109.68% to $130000.0 in 2022, then soared by 206.15% to $398000.0 in 2023, then fell by 22.11% to $310000.0 in 2024, then surged by 48.39% to $460000.0 in 2025.
  • The last three Accumulated Expenses figures came in at $460000.0 (Q4 2025), $530000.0 (Q3 2025), and $534000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Nexgel 31,199.58 -1.34 Mn 819,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 460,000.00
Sep 30, 2025 530,000.00
Jun 30, 2025 534,000.00
Mar 31, 2025 334,000.00
Dec 31, 2024 310,000.00
Sep 30, 2024 609,000.00
Jun 30, 2024 98,000.00
Mar 31, 2024 55,000.00
Dec 31, 2023 398,000.00
Sep 30, 2023 152,000.00
Jun 30, 2023 202,000.00
Mar 31, 2023 112,000.00
Dec 31, 2022 130,000.00
Sep 30, 2022 48,000.00
Jun 30, 2022 85,000.00
Mar 31, 2022 57,000.00
Dec 31, 2021 62,000.00
Sep 30, 2021 77,000.00
Jun 30, 2021 70,000.00
Mar 31, 2021 89,000.00
Dec 31, 2020 90,000.00
Sep 30, 2020 94,000.00
Jun 30, 2020 81,000.00
Mar 31, 2020 72,000.00
Dec 31, 2019 27,000.00
Sep 30, 2019 19,000.00
Jun 21, 2019 395,000.00
Dec 31, 2018 108,000.00